Yaron Werber
Stock Analyst at TD Cowen
(4.95)
# 135
Out of 5,010 analysts
771
Total ratings
59.3%
Success rate
27.1%
Average return
Main Sectors:
Stocks Rated by Yaron Werber
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IONS Ionis Pharmaceuticals | Reiterated: Buy | $84 | $45.89 | +83.05% | 47 | Sep 23, 2026 | |
| AMGN Amgen | Reiterated: Buy | $452 | $423.64 | +6.69% | 75 | Sep 22, 2026 | |
| ROIV Roivant Sciences | Rated: Buy | $50 → $55 | $36.50 | +50.68% | 27 | Sep 9, 2026 | |
| RARE Ultragenyx Pharmaceutical | Rated: Buy | $49 → $18 | $15.32 | +17.49% | 46 | Sep 3, 2026 | |
| ARGX argenx SE | Reiterated: Buy | $1,146 → $1,353 | $970.66 | +39.39% | 56 | Aug 17, 2026 | |
| ASND Ascendis Pharma | Reiterated: Buy | $325 → $341 | $228.07 | +49.52% | 28 | Aug 13, 2026 | |
| KLRA Kailera Therapeutics | Reiterated: Buy | $57 | $10.99 | +418.65% | 5 | Aug 13, 2026 | |
| LEGN Legend Biotech | Rated: Hold | $29 → $24 | $18.82 | +27.52% | 20 | Aug 12, 2026 | |
| SEPN Septerna | Reiterated: Buy | n/a | $39.13 | - | 8 | Aug 11, 2026 | |
| GMAB Genmab | Rated: Buy | $43 | $35.57 | +20.89% | 26 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $1.87 | - | 25 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $18.36 | - | 19 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $150 | $87.16 | +72.10% | 12 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $55 | $58.65 | -6.22% | 35 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $424 → $454 | $365.27 | +24.29% | 45 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 | $25.88 | +131.84% | 21 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $5.62 | - | 19 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $227 | $267.57 | -15.27% | 1 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.6254 | - | 14 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $5.19 | - | 11 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $18.33 | - | 3 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1.43 | - | 12 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $27.20 | - | 5 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $31.64 | - | 14 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $3.52 | - | 15 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $94 | $98.57 | -4.64% | 28 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $4.63 | - | 6 | Apr 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0001 | - | 12 | Mar 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $2.62 | - | 11 | Mar 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $230 | $388.41 | n/a | 1 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $4.13 | n/a | 4 | Mar 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $46.26 | n/a | 1 | Mar 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $25 → $3 | $6.79 | n/a | 6 | Jun 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $7.05 | n/a | 2 | Nov 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $684 → $565 | $750.51 | n/a | 30 | Feb 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $8.54 | n/a | 1 | Dec 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $2.59 | n/a | 10 | Aug 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $3.14 | n/a | 6 | Feb 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $3.64 | n/a | 6 | Dec 31, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $31.66 | n/a | 4 | Aug 12, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $497 → $345 | $227.07 | n/a | 16 | Feb 25, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $120 → $110 | $151.28 | n/a | 13 | Feb 25, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $266 → $94 | $9.78 | n/a | 5 | Sep 3, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $137 → $132 | $33.30 | n/a | 2 | Feb 18, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $37 | $8.05 | n/a | 1 | Nov 10, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $18.64 | n/a | 3 | Apr 22, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $7 → $5 | $48.89 | n/a | 5 | Jun 4, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $63 → $100 | $526.73 | n/a | 7 | Apr 19, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $3 | $0.0001 | n/a | 1 | Mar 12, 2012 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $49.35 | n/a | 1 | Nov 17, 2010 |
Ionis Pharmaceuticals
Sep 23, 2026
Reiterated: Buy
Price Target: $84
Current: $45.89
Upside: +83.05%
Amgen
Sep 22, 2026
Reiterated: Buy
Price Target: $452
Current: $423.64
Upside: +6.69%
Roivant Sciences
Sep 9, 2026
Rated: Buy
Price Target: $50 → $55
Current: $36.50
Upside: +50.68%
Ultragenyx Pharmaceutical
Sep 3, 2026
Rated: Buy
Price Target: $49 → $18
Current: $15.32
Upside: +17.49%
argenx SE
Aug 17, 2026
Reiterated: Buy
Price Target: $1,146 → $1,353
Current: $970.66
Upside: +39.39%
Ascendis Pharma
Aug 13, 2026
Reiterated: Buy
Price Target: $325 → $341
Current: $228.07
Upside: +49.52%
Kailera Therapeutics
Aug 13, 2026
Reiterated: Buy
Price Target: $57
Current: $10.99
Upside: +418.65%
Legend Biotech
Aug 12, 2026
Rated: Hold
Price Target: $29 → $24
Current: $18.82
Upside: +27.52%
Septerna
Aug 11, 2026
Reiterated: Buy
Price Target: n/a
Current: $39.13
Upside: -
Genmab
Aug 7, 2026
Rated: Buy
Price Target: $43
Current: $35.57
Upside: +20.89%
Aug 6, 2026
Reiterated: Hold
Price Target: n/a
Current: $1.87
Upside: -
Aug 6, 2026
Reiterated: Buy
Price Target: n/a
Current: $18.36
Upside: -
Aug 5, 2026
Rated: Buy
Price Target: $150
Current: $87.16
Upside: +72.10%
Aug 5, 2026
Reiterated: Buy
Price Target: $55
Current: $58.65
Upside: -6.22%
Aug 5, 2026
Reiterated: Buy
Price Target: $424 → $454
Current: $365.27
Upside: +24.29%
Aug 4, 2026
Reiterated: Buy
Price Target: $60
Current: $25.88
Upside: +131.84%
Jun 1, 2026
Reiterated: Buy
Price Target: n/a
Current: $5.62
Upside: -
May 18, 2026
Reiterated: Buy
Price Target: $227
Current: $267.57
Upside: -15.27%
May 15, 2026
Downgraded: Hold
Price Target: n/a
Current: $0.6254
Upside: -
May 13, 2026
Reiterated: Buy
Price Target: n/a
Current: $5.19
Upside: -
May 13, 2026
Reiterated: Buy
Price Target: n/a
Current: $18.33
Upside: -
May 12, 2026
Reiterated: Buy
Price Target: n/a
Current: $1.43
Upside: -
May 8, 2026
Reiterated: Buy
Price Target: n/a
Current: $27.20
Upside: -
May 7, 2026
Reiterated: Buy
Price Target: n/a
Current: $31.64
Upside: -
May 7, 2026
Reiterated: Buy
Price Target: n/a
Current: $3.52
Upside: -
May 5, 2026
Reiterated: Hold
Price Target: $94
Current: $98.57
Upside: -4.64%
Apr 21, 2026
Downgraded: Hold
Price Target: n/a
Current: $4.63
Upside: -
Mar 31, 2026
Rated: Hold
Price Target: n/a
Current: $0.0001
Upside: -
Mar 26, 2026
Reiterated: Buy
Price Target: n/a
Current: $2.62
Upside: -
May 21, 2025
Reiterated: Buy
Price Target: $230
Current: $388.41
Upside: n/a
Mar 14, 2024
Downgraded: Hold
Price Target: n/a
Current: $4.13
Upside: n/a
Mar 11, 2024
Reiterated: Buy
Price Target: n/a
Current: $46.26
Upside: n/a
Jun 26, 2023
Reiterated: Hold
Price Target: $25 → $3
Current: $6.79
Upside: n/a
Nov 1, 2022
Downgraded: Hold
Price Target: n/a
Current: $7.05
Upside: n/a
Feb 8, 2021
Reiterated: Hold
Price Target: $684 → $565
Current: $750.51
Upside: n/a
Dec 14, 2020
Initiated Coverage: Buy
Price Target: n/a
Current: $8.54
Upside: n/a
Aug 5, 2020
Reiterated: Buy
Price Target: n/a
Current: $2.59
Upside: n/a
Feb 21, 2020
Rated: Hold
Price Target: n/a
Current: $3.14
Upside: n/a
Dec 31, 2019
Reiterated: Hold
Price Target: n/a
Current: $3.64
Upside: n/a
Aug 12, 2019
Reiterated: Hold
Price Target: n/a
Current: $31.66
Upside: n/a
Feb 25, 2016
Rated: Buy
Price Target: $497 → $345
Current: $227.07
Upside: n/a
Feb 25, 2016
Initiated Coverage: Buy
Price Target: $120 → $110
Current: $151.28
Upside: n/a
Sep 3, 2015
Initiated Coverage: Buy
Price Target: $266 → $94
Current: $9.78
Upside: n/a
Feb 18, 2015
Reiterated: Hold
Price Target: $137 → $132
Current: $33.30
Upside: n/a
Nov 10, 2014
Initiated Coverage: Buy
Price Target: $37
Current: $8.05
Upside: n/a
Apr 22, 2014
Upgraded: Hold
Price Target: n/a
Current: $18.64
Upside: n/a
Jun 4, 2013
Reiterated: Hold
Price Target: $7 → $5
Current: $48.89
Upside: n/a
Apr 19, 2013
Reiterated: Buy
Price Target: $63 → $100
Current: $526.73
Upside: n/a
Mar 12, 2012
Downgraded: Hold
Price Target: $3
Current: $0.0001
Upside: n/a
Nov 17, 2010
Downgraded: Hold
Price Target: n/a
Current: $49.35
Upside: n/a